Investors in Megan Holdings face a Sept. 8 lead plaintiff deadline after a class action alleged a pump-and-dump scheme drove a 93.4% single-day stock collapse.
The complaint, filed in the U.S. District Court for the Southern District of New York, alleges impersonators posing as financial advisors touted MGN shares in online forums and social media to create a buying frenzy among retail investors, according to Levi & Korsinsky, the firm representing the class.
Megan, a Malaysian aquaculture company, completed its initial public offering Sept. 29, 2025, selling 1.25 million ordinary shares at $4.00 each for $5 million in gross proceeds. The stock rose more than 400 percent from $1.23 on Feb. 25, 2026, to an intraday high of $5.18 on March 25, before collapsing to $0.28 the next day.
The lawsuit names the company, CEO Darren Hoo, CFO Ng Kai Tie, underwriter D. Boral Capital LLC and auditor WWC P.C. as defendants. Investors who bought MGN shares between Sept. 26, 2025, and March 25, 2026, must file a lead plaintiff motion by Sept. 8, 2026.
The complaint alleges the offering documents failed to disclose that the company was the subject of a market manipulation scheme and that underwriter D. Boral Capital had a track record of microcap IPOs that suffered similar manipulation-driven collapses. The firm's prior deals include Park Ha Biological Technology, which lost 94 percent of its value, and Masonglory, which fell about 97.6 percent from its highest close.
The complaint also alleges Megan suffered material weaknesses in internal accounting and financial reporting controls, and that auditor WWC issued a clean opinion despite those deficiencies. WWC served as Megan's auditor from 2022 through Dec. 15, 2025.
The action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, as well as Sections 11, 12(a)(2) and 15 of the Securities Act of 1933.
The Sept. 8 deadline applies only to investors seeking lead plaintiff appointment. Class members who do not apply can still participate in any settlement or recovery, and investors who bought during the class period and sold at a loss remain eligible regardless of whether they still hold the shares.
The collapse leaves MGN trading well below its $0.28 close, with the stock's recovery hinging on the litigation's outcome. The court's appointment of a lead plaintiff, expected after the Sept. 8 deadline, will determine how the case proceeds.
This article is for informational purposes only and does not constitute investment advice.